AzTrials
AzTrials

Lower Limb InjuryNCT03578705

Muscle Quality and Percentage of Fat Following a Lower Limb Injury

An observational study of Lower Limb Injury and Injury Trauma, run by McGill University Health Centre/Research Institute of the McGill University Health Centre at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the study is to longitudinally evaluate patient muscle quality in trauma patients with bed rest or altered weight-bearing with the help of a consumer approved non-proprietary muscle impedance-measuring device. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Lower Limb Injury, Injury Trauma
What is being tested?
Electrical Impedance Myography unit or "EIM"
Type of treatment
Medical device
How many people
100 participants
Where
1 siteCanada
Study dates
15 Mar 2016to 31 Dec 2021
How long will I take part?
6 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Any adult patient admitted at the Montreal General Hospital for orthopedic surgery because of a lower limb injury preventing them to walk without aid for a certain time.

Who may be able to join

  • Trauma requiring admission to orthopedic surgery because of a lower limb injury
  • Ability and willingness to participate
  • Steady state medical condition before trauma

Who cannot join

  • Age <18
  • Pre-existing condition that caused pain or limited weight-bearing on either lower extremity before sustaining trauma (for example the use of walking aids)
  • Pre-existing medical conditions that will confound the study outcomes (muscle conditions) and are known to prevent return to function
  • Pregnancy
  • Implanted electrical device such as heart pacemakers

Trial locations and contacts

1 site in 1 country.

Mary Amedeo contact

514-934-1934 ext. 43386

Canada1 site, 1 recruiting
  • McGill University Health Centre

    Montreal, Quebec, H3G 1A4

    Mary Amedeo, 514-934-1934 ext. 43386, mary.amedeo@muhc.mcgill.ca

    Edward J Harvey, MDCM, FRCSC

    Recruiting

Other trials in Canada

About this study

Official title: Longitudinal Evaluation of Muscle Quality in Patients With Fractures - A Prospective Observational Study

The aim of the study is to longitudinally evaluate patient muscle quality in trauma patients with bed rest or altered weight-bearing with the help of a consumer approved non-proprietary muscle impedance-measuring device. Secondary objectives are to identify patient characteristics or treatment protocols that are predictive of poor muscle quality.

Read the detailed description

The study investigators will identify eligible patients through patient consultations from the Emergency Room. There are 100 patients expected to be enrolled in the study. This study will be carried out at the Montreal General Hospital. Inclusion criteria include patients that have had a trauma requiring admission to orthopedic surgery, that have the ability and willingness to participate that were in a steady state medical condition before trauma.

Although the study investigators may discuss the study with the patient, the consent and enrolment will be performed exclusively by the study assistant who is not directly implicated in the patient's care.

This is an observational study, therefore, there will be no randomization and no study intervention.

The following baseline patient characteristics will be recorded for each enrolled participant: age, sex, occupation, smoker, medical comorbidities, AO classification of the fractures and muscle trauma, the date of the injury and date of the surgery if performed.

A consumer approved non-proprietary muscle impedance-measuring device (Electrical Impedance Myography unit or "EIM") will be applied to the muscle groups of interest. The device is self-contained, battery-powered and certified for use on humans. When applied to the skin, a very weak electrical current is passed between the outer two electrodes. This current is high frequency and alternating in nature. As the current moves through the skin, the subcutaneous fat and the muscle, it loses a little bit of energy due to the resistance of the tissue and this change is then measured. This will be done as soon as possible after the trauma and admission during a daytime visit. The EIM will be used every two days until discharge or the patient has reached a recovery plateau in a physical rehabilitation program. Patients' muscle quality will also be measured at each follow-up visit for 100 weeks and patients will be asked to complete two questionnaires.

Each patient will have a unique identification number used to link the patient information, device and data together.

It is expected for most patients to have decreasing muscle quality and increasing fat percentage as a result of deconditioning. There is no longitudinal data on the time period over which this would occur. There is also little data on how recovery occurs after the period of healing.

This study utilizes new technology that permits objective insight into the post-operative period by providing qualitative measurements. It has been used previously in clinical studies on patients with neuromuscular degenerative disease with reproducible and consistent results. The research team anticipates being able to pinpoint specific targets for mobilization goals and rehabilitation techniques depending on the time frame and muscle groups involved with deconditioning.

Being tested
Electrical Impedance Myography unit or "EIM"
Keywords
Orthopedic trauma
Medical subject headings
Leg Injuries, Accidental Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Electrical Impedance Myography unit or "EIM"Device

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Muscle Quality

    The muscle quality number given by the device is a number given by the company making the device with an arbitrary standard.

    Measured: Every two-day while in bed rest at the hospital and at every follow-up visit up to 100 weeks after injury

  2. Percentage of Fat Measurement

    The percentage of fat is given by the device

    Measured: Every two-day while in bed rest at the hospital and at every follow-up visit up to 100 weeks after injury

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jul 2018
  2. Study start15 Mar 2016
  3. Primary completion31 Dec 2020 (estimated)
  4. Study completion31 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
100 participants (estimated)
Target duration
6 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT03578705
Sponsor's protocol ID
15-056-MUHC
Status last verified
May 2020
First submitted
2 Aug 2017
Last updated
15 May 2020
Results posted
No
Data monitoring committee
No
Individual data sharing
No: We will share the results from the collected data in a publication. However, we will not share individual participant data for reasons of confidentiality.

Questions about this trial

What is this clinical trial studying?

An observational study of Lower Limb Injury and Injury Trauma, run by McGill University Health Centre/Research Institute of the McGill University Health Centre at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mary Amedeo (514-934-1934 ext. 43386), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Muscle Quality (time frame: Every two-day while in bed rest at the hospital and at every follow-up visit up to 100 weeks after injury). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 May 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in